News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

ARTEMIS-008: Risvutatug rezetecan shows promise as new standard of care for relapsed SCLC
21 Oct 2026
byStephen Padilla
Treatment with the B7-H3-directed antibody-drug conjugate risvutatug rezetecan (Ris-Rez) results in significant improvements in overall survival (OS) compared with topotecan in patients with relapsed small-cell lung cancer (SCLC) who had progressed after receiving platinum-based chemotherapy, as shown by the results of the phase III ARTEMIS-008 trial.
21 Oct 2026

Regular walking reduces MACE in individuals with hypertension
21 Oct 2026
byAudrey Abella
In a large study using UK Biobank data, incremental increases in daily step count are associated with a significantly lower risk of major adverse cardiovascular events (MACE) in adults with hypertension, especially when accrued at a higher stepping intensity.
21 Oct 2026






